Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||
| Net Income | -10,519 | -33,629 |
| Depreciation Amortization | 585 | 1,913 |
| Accounts receivable | 759 | N/A |
| Accounts payable and accrued liabilities | 407 | N/A |
| Other Working Capital | 2,023 | -1,872 |
| Other Operating Activity | -265 | 1,908 |
| Operating Cash Flow | $-7,010 | $-31,680 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -152 | -1,355 |
| Purchase Sale Intangibles | -145 | N/A |
| Other Investing Activity | -681 | -1,678 |
| Investing Cash Flow | $-833 | $-3,033 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 6,656 | N/A |
| Debt Repayment | -606 | N/A |
| Common Stock Issued | 327 | N/A |
| Other Financing Activity | -243 | -1,023 |
| Financing Cash Flow | $6,134 | $-1,023 |
| Exchange Rate Effect | 131 | -102 |
| Beginning Cash Position | 18,069 | 53,907 |
| End Cash Position | 16,491 | 18,069 |
| Net Cash Flow | $-1,578 | $-35,838 |
| Free Cash Flow | ||
| Operating Cash Flow | -7,010 | -31,680 |
| Capital Expenditure | -152 | N/A |
| Free Cash Flow | -7,162 | -31,680 |